Revisiting the tolerogenicity of epidermal Langerhans cells

Immunology and Cell Biology

Volumn 88, Issue 4, 2010, Pages 381-386

  Lutz, Manfred B ^a   Döhler, Anja ^a   Azukizawa, Hiroaki ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Langerhans cells; Steady state; Tolerance

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL SUBPOPULATION; CELL TRANSPORT; CELLULAR IMMUNITY; DENDRITIC CELL; EPIDERMIS CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGICAL TOLERANCE; LANGERHANS CELL; NONHUMAN; REVIEW; SKIN ALLERGY; SKIN CELL; T LYMPHOCYTE;

ANIMALS; IMMUNE TOLERANCE; LANGERHANS CELLS; MICE;

MUS;

EID: 77952242473     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.17     Document Type: Review

References (106)

1. Langerhans P. über die Nerven der menschlichen Haut. Virchows Arch [A] 1886; 44: 325-337.
2. Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979; 282: 324-326.
3. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985; 161: 526-546. (Pubitemid 15142803)
4. Mishima Y. Melanosomes in phagocytic vacuoles in Langerhans cells. J Cell Biol 1966; 30: 417-423.
5. Parr BM, Kepple L, Parr EL. Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrous cycle. Biol Reprod 1991; 45: 252-260.
6. Wolff K, Schreiner E. Uptake, intracellular transport and degradation of exogenous protein by Langerhans cells. An electron microscopic-cytochemical study using peroxidase as tracer substance. J Invest Dermatol 1970; 54: 37-47.
7. Silberberg-Sinakin I, Thorbecke GJ, Baer RL, Rosenthal SA, Berezowsky V. Antigenbearing langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 1976; 25: 137-151.
8. Kelly RH, Balfour BM, Armstrong JA, Griffiths S. Functional anatomy of lymph nodes. II. Peripheral lymph-borne mononuclear cells. Anat Rec 1978; 190: 5-21.
9. Bujdoso R, Hopkins J, Dutia BM, Young P, McConnell I. Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J ExpMed 1989; 170: 1285-1301.
10. Yoshino M, Yamazaki H, Shultz LD, Hayashi S. Constant rate of steady-state self-antigen trafficking from skin to regional lymph nodes. Int Immunol 2006; 18: 1541-1548.
11. Lutz MB, Kurts C. Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur J Immunol 2009; 39: 2325-2330.
12. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat rev 2008; 8: 935-947.
13. Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 2008; 38: 2369-2376.
14. Imai Y, Hayashi N, Yasuda K, Tsutsui H, Mizutani H, Nakanishi K. Freshly isolated Langerhans cells negatively regulate naive T cell activation in response to peptide antigen through cell-to-cell contact. J Dermatol Sci 2008; 51: 19-29.
15. Stoitzner P, Tripp CH, Douillard P, Saeland S, Romani N. Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J Invest Dermatol 2005; 125: 116-125.
16. Weinlich G, Heine M, Stossel H, Zanella M, Stoitzner P, Ortner U et al. Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J Invest Dermatol 1998; 110: 441-448.
17. Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, de Bovis B et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 2009.
18. Shklovskaya E, Roediger B, Fazekas de St Groth B. Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo. J Immunol 2008; 181: 418-430.
19. Obhrai JS, Oberbarnscheidt M, Zhang N, Mueller DL, Shlomchik WD, Lakkis FG et al. Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol 2008; 128: 1950-1955.
20. Wang L, Jameson SC, Hogquist KA. Epidermal Langerhans cells are not required for UV-induced immunosuppression. J Immunol 2009; 183: 5548-5553.
21. Kissenpfennig A, Malissen B. Langerhans cells-revisiting the paradigm using genetically engineered mice. Trends Immunol 2006; 27: 132-139.
22. Romani N, Ebner S, Tripp CH, Flacher V, Koch F, Stoitzner P. Epidermal Langerhans cells-changing views on their function in vivo. Immunol Lett 2006; 106: 119-125.
23. Bennett CL, Clausen BE. DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol 2007; 28: 525-531.
24. Sauder DN, Noonan FP, DeFabo EC, Katz SI. Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF). J Invest Dermatol 1983; 80: 485-489.
25. Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells . Induction of specific clonal anergy in CD4T helper cells. J Immunol 1991; 146: 485-491.
26. Beissert S, Ullrich SE, Hosoi J, Granstein RD. Supernatants from UVB radiationexposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content. J Leukoc Biol 1995; 58: 234-240.
27. Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur J Dermatol 2003; 13: 515-523.
28. Yoshiki R, Kabashima K, Sugita K, Atarashi K, Shimauchi T, Tokura Y. IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. J Invest Dermatol 2009; 129: 705-713.
29. Igyarto BZ, Jenison MC, Dudda JC, Roers A, Muller W, Koni PA et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J Immunol 2009; 183: 5085-5093.
30. Granstein RD, Matsui MS. UV radiation-induced immunosuppression and skin cancer. Cutis 2004; 74: 4-9.
31. Feliciani C, Gupta AK, Sauder DN. Keratinocytes and cytokine/growth factors. Crit Rev Oral Biol Med 1996; 7: 300-318.
32. Borkowski TA, Letterio JJ, Mackall CL, Saitoh A, Wang XJ, Roop DR et al. A role for TGFbeta1 in Langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J Clin Invest 1997; 100: 575-581.
33. Kaplan DH, Li MO, Jenison MC, Shlomchik WD, Flavell RA, Shlomchik MJ. Autocrine/ paracrine TGF-beta1 is required for the development of epidermal Langerhans cells. J Exp Med 2007; 204: 2545-2552.
34. Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, Kuhl C et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003; 4: 380-386.
35. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Goldenberg D et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 2004; 23: 969-979.
36. Nagao K, Ginhoux F, Leitner WW, Motegi S, Bennett CL, Clausen BE et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci USA 2009; 106: 3312-3317.
37. Strobl H, Riedl E, Scheinecker C, Bello FC, Pickl WF, Rappersberger K et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol 1996; 157: 1499-1507. (Pubitemid 126449086)
38. Bonham CA, Lu L, Banas RA, Fontes P, Rao AS, Starzl TE et al. TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Transpl Immunol 1996; 4: 186-191.
39. Strobl H, Knapp W. TGF-beta1 regulation of dendritic cells. Microbes Infect 1999; 1: 1283-1290.
40. Hemmi H, Yoshino M, Yamazaki H, Naito M, Iyoda T, Omatsu Y et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factorbeta1-dependent cells. Int Immunol 2001; 13: 695-704.
41. Gruschwitz MS, Hornstein OP. Expression of transforming growth factor type beta on human epidermal dendritic cells. J Invest Dermatol 1992; 99: 114-116.
42. Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 1990; 94: 101S-107S.
43. Enk AH, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992; 149: 92-95.
44. Takashima A, Bergstresser PR. Cytokine-mediated communication by keratinocytes and Langerhans cells with dendritic epidermal T cells. Semin Immunol 1996; 8: 333-339. (Pubitemid 26418371)
45. Girardi M, Lewis J, Glusac E, Filler R, Geng L, Hayday A et al. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med 2002; 195: 855-867.
46. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998; 7: 81-96.
47. Lambrecht BN. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir Res 2001; 2: 133-138.
48. Kodali S, Ding W, Huang J, Seiffert K, Wagner JA, Granstein RD. Vasoactive intestinal peptide modulates Langerhans cell immune function. J Immunol 2004; 173: 6082-6088.
49. Ding W, Wagner JA, Granstein RD. CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappaB activation. J Invest Dermatol 2007; 127: 2357-2367.
50. Meindl S, Rot A, Hoetzenecker W, Kato S, Cross HS, Elbe-Burger A. Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells. Br J Dermatol 2005; 152: 231-241.
51. Lob S, Konigsrainer A, Rammensee HG, Opelz G, Terness P. Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 2009; 9: 445-452.
52. von Bubnoff D, Bausinger H, Matz H, Koch S, Hacker G, Takikawa O et al. Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. J Invest Dermatol 2004; 123: 298-304.
53. Jux B, Kadow S, Esser C. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J Immunol 2009; 182: 6709-6717.
54. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol 2002; 168: 3079-3087.
55. Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009; 64: 1699-1714.
56. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005; 22: 643-654.
57. Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, Malissen B. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 2007; 204: 3119-3131.
58. Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, Helft J et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J ExpMed 2007; 204: 3133-3146.
59. Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH et al. Identification of a novel population of Langerin+ dendritic cells. J Exp Med 2007; 204: 3147-3156.
60. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005; 23: 611-620.
61. Wang L, Bursch LS, Kissenpfennig A, Malissen B, Jameson SC, Hogquist KA. Langerin expressing cells promote skin immune responses under defined conditions. J Immunol 2008; 180: 4722-4727.
62. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005; 169: 569-576.
63. Kissenpfennig A, Ait-Yahia S, Clair-Moninot V, Stossel H, Badell E, Bordat Y et al. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol Cell Biol 2005; 25: 88-99.
64. Bennett CL, Noordegraaf M, Martina CA, Clausen BE. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol 2007; 179: 6830-6835.
65. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002; 99: 351-358.
66. Azukizawa H, Kosaka H, Sano S, Heath WR, Takahashi I, Gao XH et al. Induction of Tcell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 2003; 33: 1879-1888.
67. Mayerova D, Parke EA, Bursch LS, Odumade OA, Hogquist KA. Langerhans cells activate naive self-antigen-specific CD8T cells in the steady state. Immunity 2004; 21: 391-400.
68. Stoitzner P, Tripp CH, Eberhart A, Price KM, Jung JY, Bursch L et al. Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 2006; 103: 7783-7788.
69. Ludwig-Portugall I, Hamilton-Williams EE, Gottschalk C, Kurts C. Cutting edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. J Immunol 2008; 181: 4447-4451.
70. Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005; 22: 19-29.
71. Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004; 199: 1401-1408.
72. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005; 6: 1219-1227.
73. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004; 21: 279-288.
74. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23: 445-449.
75. Waithman J, Allan RS, Kosaka H, Azukizawa H, Shortman K, Lutz MB et al. Skinderived dendritic cells can mediate deletional tolerance of class I-restricted selfreactive T cells. J Immunol 2007; 179: 4535-4541.
76. Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, Caminschi I et al. Crosspresentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 2009; 10: 488-495.
77. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25: 153-162.
78. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol 2005; 174: 2220-2227.
79. Bianco NR, Kim SH, Ruffner MA, Robbins PD. Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum 2009; 60: 380-389.
80. Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD. MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner. J Immunol 2007; 179: 2235-2241.
81. Li XB, Zhang ZR, Schluesener HJ, Xu SQ. Role of exosomes in immune regulation. J Cell Mol Med 2006; 10: 364-375.
82. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. A role for class A scavenger receptor in dendritic cell nibbling fromlive cells. J Immunol 2003; 170: 2302-2309.
83. Qi H, Egen JG, Huang AY, Germain RN. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 2006; 312: 1672-1676.
84. Lutz MB, Rovere P, Kleijmeer MJ, Rescigno M, Assmann CU, Oorschot VM et al. Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/ lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells. J Immunol 1997; 159: 3707-3716.
85. Grubauer G, Romani N, Kofler H, Stanzl U, Fritsch P, Hintner H. Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies. J Invest Dermatol 1986; 87: 466-471.
86. Bhoopat L, Eiangleng L, Rugpao S, Frankel SS, Weissman D, Lekawanvijit S et al. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients. Mod Pathol 2001; 14: 1263-1269.
87. de Witte L, Nabatov A, Geijtenbeek TB. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol Med 2008; 14: 12-19.
88. Cunningham AL, Harman AN, Donaghy H. DC-SIGN ¢AIDS¢ HIV immune evasion and infection. Nat Immunol 2007; 8: 556-558.
89. Harman AN, Wilkinson J, Bye CR, Bosnjak L, Stern JL, Nicholle M et al. HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol 2006; 177: 7103-7113.
90. Smed-Sorensen A, Lore K, Vasudevan J, Louder MK, Andersson J, Mascola JR et al. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 2005; 79: 8861-8869.
91. Wilflingseder D, Mullauer B, Schramek H, Banki Z, Pruenster M, Dierich MP et al. HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. J Immunol 2004; 173: 7497-7505.
92. Anand AR, Prasad A, Bradley RR, Deol YS, Nagaraja T, Ren X et al. HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1. Blood 2009; 114: 3588-3600.
93. Barratt-Boyes SM, Zimmer MI, Harshyne L. Changes in dendritic cell migration and activation during SIV infection suggest a role in initial viral spread and eventual immunosuppression. J Med Primatol 2002; 31: 186-193.
94. Terzieva V. Regulatory T cells and HIV-1 infection. Viral Immunol 2008; 21: 285-291.
95. Sempere JM, Soriano V, Benito JM. T regulatory cells and HIV infection. AIDS Rev 2007; 9: 54-60.
96. Liu B, Woltman AM, Janssen HL, Boonstra A. Modulation of dendritic cell function by persistent viruses. J Leukoc Biol 2009; 85: 205-214.
97. Blauvelt A, Katz SI. The skin as target, vector, and effector organ in human immunodeficiency virus disease. J Invest Dermatol 1995; 105: 122S-126S.
98. Grundstrom S, Andersson J. Studies of HIV-associated immune responses in lymphoid compartments. Curr HIV/AIDS Rep 2006; 3: 32-38.
99. Santegoets SJ, Gibbs S, Kroeze K, van de Ven R, Scheper RJ, Borrebaeck CA et al. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol 2008; 84: 143-151.
100. Senti G, Johansen P, Kundig TM. Intralymphatic immunotherapy. Curr Opin Allergy Clin Immunol 2009; 9: 537-543.
101. Bynoe MS, Evans JT, Viret C, Janeway Jr CA. Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis. Immunity 2003; 19: 317-328.
102. O'Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 2004; 114: 1372-1378.
103. Senti G, Graf N, Haug S, Ruedi N, von Moos S, Sonderegger T et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 2009; 124: 997-1002.
104. Allam JP, Bieber T, Novak N. Dendritic cells as potential targets for mucosal immunotherapy. Curr Opin Allergy Clin Immunol 2009; 9: 554-557.
105. Akdis CA, Barlan IB, Bahceciler N, Akdis M. Immunological mechanisms of sublingual immunotherapy. Allergy 2006; 61 (Suppl) 81: 11-14.
106. Scadding G, Durham S. Mechanisms of sublingual immunotherapy. J Asthma 2009; 46: 322-334.